News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 123
- Sources here
- 20
- Companies here
- 5
Active search
123 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Scholastic (NASDAQ:SCHL) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS
Scholastic (NASDAQ:SCHL) reported quarterly earnings of $2.19 EPS, beating consensus estimates by $0.03, though revenue of $476.1 million fell short of expectations. The company's stock rose 0.2% to $46.44 after the announcement, trading near its 52-week high. Scholastic also increased its quarterly dividend to …
Scholastic Corp (SCHL) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
Scholastic Corp (SCHL) reported a 6% decrease in Q4 2026 revenue and a 3% decrease for the full fiscal year, despite a 32% increase in adjusted operating income. The company saw strong performance in Book Fairs and Entertainment segments, and increased its dividend by …
Scholastic’s Sales, Earnings Dipped in Fiscal 2026
Scholastic reported a 3% decrease in total revenue to $1.58 billion and a slight dip in operating income for the fiscal year ending May 31, 2026. Despite these results, CEO Peter Warwick highlighted significant progress in the company's multi-year transformation, focusing on its proprietary …
Scholastic Corp To Go Ex-Dividend On August 31st, 2026 With 0.25 USD Dividend Per Share
Scholastic Corp is scheduled to go ex-dividend on August 31st, 2026. The company will issue a dividend of 0.25 USD per share. Investors should note this date for dividend eligibility.
Scholastic: Fiscal Q4 Earnings Snapshot
Scholastic Corp. (SCHL) reported a profit of $9.4 million, or 45 cents per share, for its fiscal fourth quarter, with adjusted earnings of $2.19 per share. The company posted revenues of $476.1 million for the quarter and $1.58 billion for the full fiscal year, …
Scholastic reports FY2026 adjusted EBITDA $151.5M; operating income $15.2M, revenue $1.5819B
Scholastic announced its fiscal year 2026 results, reporting $1.5819 billion in revenue and $15.2 million in operating income. The company's adjusted EBITDA reached $151.5 million, marking a 4% year-over-year increase, and diluted EPS was $2.34. Scholastic also returned $288.6 million to shareholders and significantly …
Scholastic's annual dividend rate rises to $1 per share for fiscal 2027
Scholastic Corporation (NASDAQ: SCHL) announced a 25% increase in its regular quarterly dividend, raising it from $0.20 to $0.25 per share. This increase, applicable to both Class A and Common Stock, takes effect with the first quarter of fiscal 2027, making the new indicated …
Press Release: Scholastic Corporation Increases Quarterly Dividend by 25%
Scholastic Corporation (NASDAQ: SCHL) announced a 25% increase in its quarterly cash dividend to $0.20 per share, payable on September 15, 2026, to shareholders of record as of August 29, 2026. This marks the fifth dividend increase in the past five years and reflects …
Dick Robinson’s Will Challenged by Son
Five years after Dick Robinson, former Scholastic CEO, left a controlling stake in the company to a non-family member, his son, John "Ben" Robinson, has filed a lawsuit to challenge the will. The son alleges "undue influence and/or duress" by Iole Lucchese and Andrew …
What To Expect From Scholastic’s (SCHL) Q2 Earnings
Scholastic (NASDAQ:SCHL) is set to report its Q2 earnings this Thursday afternoon. Analysts expect a 1.7% year-on-year revenue growth, a slowdown from the previous year. The company has missed revenue estimates multiple times in the past two years, but investors have shown confidence in …
SRRK Reiterated by Wedbush -- Price Target Maintained at $58
Wedbush analyst David Nierengarten has reiterated an "Outperform" rating for Scholar Rock Holding (SRRK), maintaining a price target of $58.00. Despite this positive outlook, the company has a low GF Score™ of 30/100 and has seen $0.9 million in insider selling over the past …
Law firm investigates Scholar Rock officers for possible shareholder duty breaches
Kuehn Law, PLLC is investigating Scholar Rock Holding Corp (NASDAQ: SRRK) officers and directors for potential breaches of fiduciary duties and self-dealing, which could entitle shareholders to damages and governance reforms. The firm is urging long-term investors to come forward promptly to protect their …
Schouw & Co. share buy-back programme, week 29 2026
Aktieselskabet Schouw & Co. On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the …
SMA treatment review in Europe awaits FDA facility classification
Scholar Rock is awaiting a CHMP opinion on its apitegromab marketing authorization application (MAA) for spinal muscular atrophy (SMA) in Europe. The decision is contingent on the FDA's inspection classification of the Catalent Indiana fill-finish facility, included in the MAA. If not reclassified, Scholar …
ETFs Investing in Scholastic Corporation Stocks
This article lists various ETFs that invest in Scholastic Corporation (SL1) stocks, providing a detailed table with information such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, and NAV total return over three years. The ETFs are predominantly small-cap focused, …
11 New Hires Get Scholar Rock Equity Awards Covering 118,586 Shares
Scholar Rock (NASDAQ: SRRK) announced inducement equity awards totaling 118,586 shares of its common stock to eleven new employees. These awards consist of stock options for 33,987 shares and restricted stock units for 84,599 shares, granted under the company's 2022 Inducement Equity Plan as …
Scholar Rock (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Scholar Rock presented at the Goldman Sachs 47th Annual Global Healthcare Conference, highlighting its lead asset, apitegromab, a late-stage myostatin inhibitor for SMA, with regulatory filings underway and anticipated launches in 2026. The company plans to commercialize apitegromab in up to 50 countries and …
Scholar Rock (SRRK) Q3 2025 earnings summary
Scholar Rock's Q3 2025 earnings show a net loss of $102.2 million, up from the previous year. The delay in apitegromab's U.S. approval for SMA is attributed to manufacturing compliance issues at a third-party facility, not efficacy or safety. The company is actively working …
Scholar Rock schedules Aug. 6 webcast before markets open
Scholar Rock (NASDAQ: SRRK) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before market open. The company will host a conference call and webcast with management at 8:00 a.m. ET. Interested parties can access the live audio webcast …
Scholastic (SCHL) to Announce Earnings on Thursday
Scholastic (NASDAQ:SCHL) is expected to announce its Q4 2026 earnings on Thursday, July 23rd, after market close, with analysts forecasting $2.16 earnings per share and $517.0640 million in revenue. The company recently authorized a $200 million share repurchase program, indicating management believes its shares …